Armenia vs Belize: Access to anti-retroviral drugs, female
Armenia
52.0%
in 2024
Belize
51.0%
in 2024
Armenia rank
116th
Belize rank
118th
Access to anti-retroviral drugs, female over time
- Armenia
- Belize
How they compare
Armenia currently reports 52.0% against 51.0% in Belize, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Belize ahead.
Armenia ranks 116th and Belize ranks 118th of 141 countries.
Across the 3 decades both report, Armenia averaged higher in 1 and Belize in 2.
Head to head by decade
| Decade | Armenia | Belize | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 9.1% | 7.1% | Belize |
| 2010s | 27.2% | 37.9% | 10.7% | Belize |
| 2020s | 48.6% | 47.8% | 0.8% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Armenia or Belize?
- Armenia, at 52.0% against 51.0% in Belize as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Armenia and Belize?
- 1.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Belize?
- 25 years are reported by both, from 2000 to 2024.
- How do Armenia and Belize rank globally for access to anti-retroviral drugs, female?
- Armenia ranks 116th and Belize ranks 118th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.